"Jan. 7, 2013 -- Children whose dads were depressed during the pregnancy are more likely to exhibit emotional and behavioral problems at age 3, new research suggests.
The finding comes from an ongoing study of more than 30,000 Norwegia"...
(lidocaine hydrochloride monohydrate) Powder Intradermal Injection System
Zingo™ (lidocaine hydrochloride monohydrate) powder intradermal injection system contains 0.5 mg of sterile lidocaine hydrochloride monohydrate.
The chemical name is 2-diethylamino-2',6'-acetoxylidide, monohydrochloride, monohydrate. The molecular formula is C14H22N2O · HCl · H2O with a molecular weight of 288.8 Da. Lidocaine hydrochloride monohydrate, a local anesthetic of the amide class, has the following structural formula:
Lidocaine hydrochloride monohydrate is freely soluble in water, soluble in alcohol and chloroform, insoluble in ether, and melts at around 74–79°C.
Zingo™ (lindocaine hydrochloride monohydrate) is a ready-to-use, sterile, single-use, disposable, needle-free delivery system. Zingo™ (lindocaine hydrochloride monohydrate) consists of the following components: a drug reservoir cassette filled with 0.5 mg lidocaine hydrochloride monohydrate as a powder with a nominal particle size of 40 µm, a pressurized helium gas cylinder, and a safety interlock. The safety interlock prevents inadvertent actuation of the device. Once Zingo™ (lindocaine hydrochloride monohydrate) is pressed against the skin, the interlock is released, allowing the button to be depressed to actuate the device. A sound similar to that of a popping balloon is emitted at the time Zingo™ (lindocaine hydrochloride monohydrate) is actuated.
Last reviewed on RxList: 2/27/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Zingo Information
Report Problems to the Food and Drug Administration
Parenting and Pregnancy
Get tips for baby and you.